Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

presents

10 posts
RRoche
Roche presents new data across pharmaceuticals and diagnostics from its growing Alzheimer’s disease portfolio at CTAD 2026
Read More

Roche presents new data across pharmaceuticals and diagnostics from its growing Alzheimer’s disease portfolio at CTAD 2026

  • 2026-11-10
Updated Phase Ib/IIa Brainshuttle™ AD study data for trontinemab demonstrating rapid amyloid removal dynamics and changes in key…
RRoche
Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)
Read More

Roche presents interim phase III data showing sefaxersen significantly reduced proteinuria in people with IgA nephropathy (IgAN)

  • 2026-10-23
Sefaxersen achieved a statistically significant 43.1% reduction in proteinuria, a key indicator of kidney damage, relative to placebo…
RRoche
Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Read More

Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss

  • 2026-10-10
In the MEERKAT and SANDCAT studies, vamikibart demonstrated sustained improvements in vision and reductions in macular thickness in…
RRoche
Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions
Read More

Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions

  • 2026-10-01
New real-world results for Vabysmo in nAMD, DME and RVO reinforce robust effectiveness and durability across previously untreated…
ZZürich
BROAD ARROW PRESENTS ULTIMATE PERFORMANCE CARS AT ITS SECOND ANNUAL ZÜRICH AUCTION
Read More

BROAD ARROW PRESENTS ULTIMATE PERFORMANCE CARS AT ITS SECOND ANNUAL ZÜRICH AUCTION

  • 2026-09-03
RARE ULTIMATE SERIES MCLAREN SENNA EPITOMISES THE SPIRIT OF THE FAMOUS FORMULA ONE DRIVER | LAFERRARI REPRESENTS THE…
BBern
New Bern’s RiverTowne Players presents “Murder by Poe”
Read More

New Bern’s RiverTowne Players presents “Murder by Poe”

  • 2026-08-12
NEW BERN, N.C. (WITN) – If you’re a fan of Edgar Allen Poe and the performing arts, an…
UUBS
UBS Share Price Presents Unexpected Buying Opportunity
Read More

UBS Share Price Presents Unexpected Buying Opportunity

  • 2026-04-03
Institutional investors buy UBS stock on weakness as a costly legal case ends with minimal impact. Key dates…
NNovartis
Novartis presents Rhapsido® (remibrutinib) data at AAAAI, showing potential beyond chronic spontaneous urticaria (CSU)
Read More

Novartis presents Rhapsido® (remibrutinib) data at AAAAI, showing potential beyond chronic spontaneous urticaria (CSU)

  • 2026-02-23
Analyses from REMIX-1 & -2 studies on CSU disease control and early symptom relief will be presented Phase…
RRoche
Roche Diagnostics presents another ERE of 50 people at its headquarters in Sant Cugat del Vallès
Read More

Roche Diagnostics presents another ERE of 50 people at its headquarters in Sant Cugat del Vallès

  • 2026-02-13
BarcelonaNew job cuts in the Catalan pharmaceutical sector. Roche Diagnostics, a division of the Swiss pharmaceutical company Roche,…
RRoche
Roche Diagnostics presents another ERE of 50 people at its headquarters in Sant Cugat del Vallès
Read More

Roche Diagnostics presents another ERE of 50 people at its headquarters in Sant Cugat del Vallès

  • 2026-02-13
BarcelonaNew job cuts in the Catalan pharmaceutical sector. Roche Diagnostics, a division of the Swiss pharmaceutical company Roche,…
Switzerland
www.europesays.com